Shareholding disclosure

AXA S.A

Declared position

Threshold

Fell below threshold

Timeline

Published

08.05.2020

Transaction

04.05.2020

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK5700063

Beneficial owner

AXA S.A

Declared address

AXA S.A., 75008/Paris

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

AXA S.A

Newron Pharmaceuticals S.p.A.08.05.2020TAK5700063

Disclosure summary

AXA S.A disclosed a holding in Newron Pharmaceuticals S.p.A. that fell below the publication threshold, published by SIX Exchange Regulation on 08.05.2020, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

AXA S.A disclosed a holding in Newron Pharmaceuticals S.p.A., published on 08.05.2020.

Publication date08.05.2020

Transaction date04.05.2020

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerAXA S.A

Declared addressAXA S.A., 75008/Paris

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAK5700063

Source: SIX Exchange Regulation · Publication date: 08.05.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open